Tirzepatide is a dual glucagon-like peptide (GLP-1) and glucose-dependent insulin-releasing polypeptide (GIP) receptor agonist primarily used to treat type 2 diabetes. Its unique dual mechanism of action makes it show remarkable effects in hypoglycemia and weight management.
Mechanism of drug action
Tirzepatide activates both GLP-1 and GIP receptors:
Tirzepatide is a dual glucagon-like peptide (GLP-1) and glucose-dependent insulin-releasing polypeptide (GIP) receptor agonist primarily used to treat type 2 diabetes. Its unique dual mechanism of action makes it show remarkable effects in hypoglycemia and weight management.
Mechanism of drug action
Tirzepatide activates both GLP-1 and GIP receptors: